DS Healthcare Trading Halted

Trading of DS Healthcare shares was halted by NASDAQ following a request for “additional information requested” from the company at a last price of $0.6699. Trading will remain halted until DS Healthcare Group, Inc. has fully satisfied Nasdaq’s request for additional information. 


In other news, DS Healthcare shareholders proposed the following board members to be elected as soon as possible. One of the new board members, Yasuhiro Fujiwara, intends to increase his investment in DS Healthcare by acquiring a significant percentage of common stock on the open market. The new board will be composed of members who are completely independent to enhance corporate governance, according to the company. The proposed Board Members are:

• Yasuhiro Fujiwara. He served as the head of equities for Asia, ex-Japan at Nomura Holdings, Inc. from March 2013 to January 2015.

• Elina Yuabov, ESQ. She is the central point of contact at TD Securities for G20 regulatory training. Extensive focus on Dodd-Frank Title VII (EBCS, STRD, Port Rec, Mandatory Clearing, Margin for Non-Centrally Cleared, Swap Push Out, FATCA) EMIR, Canadian, Singapore and Australian legal regulatory analysis and implementation. SEC security based swaps regulatory analysis and execution of policies and procedures for CFTC, OSC and ASIC review and audits.

• Myron Lewis. He has more than 40 years of experience as manager, vice president, president, founder and CEO of various companies in technology, marketing communications/public relations, applied research, defense (US government) and manufacturing.